Vertex presents positive data for ALYFTREK in young cystic fibrosis patients
Go back to Vertex presents positive data for ALYFTREK in young cystic fibrosis patients| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 474.04 +1.47 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $472.57 | 52 Week High | $134.71 | |||
| Open | $467.09 | 52 Week Low | $73.31 | |||
| Day High | $477.68 | P/E | N/A | |||
| Day Low | $465.00 | EPS | $-1.98 | |||
| Volume | 485,166 | |||||
